Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even ...

Abacus Life, Inc. (ABL) shares ended the last trading session 5.4% higher at $10.40. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.1% loss over the past four weeks.ABL stays focused on consolidating its position as a leading market maker and global alternative asset manager.  The strength of partnerships with carriers and reinsurers remains a key contributor to its performance. Also, along with core business o ...

Shares of Abacus Life, Inc. (ABL) have gained 1.9% over the past four weeks to close the last trading session at $10.40, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14 indicates a potential upside of 34.6%.The mean estimate comprises three short-term price targets with a standard deviation of $2. While the lowest estimate of $12 indicates a 15.4% increase from the current p ...

ORLANDO, Fla., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced that its popular Abacus Policy Value Calculator, which recently launched its newest generation, has surpassed 150,000 individual submissions from insureds, totaling more than $87 billion in face value. “Since the original version of the calculator, we have been proud to provide over 150,000 insu ...

ORLANDO, Fla., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced that Corey McLaren has joined Abacus as Managing Director, Capital Markets. Based in Boston, Mr. McLaren has almost two decades of experience in financial services, including over fifteen years of business development and management experience directly related to life settlements. Mr. McLaren mo ...

Abacus Life, Inc. (ABL) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this company, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in ear ...

Group 1: Stock Performance and Price Targets - Abacus Life, Inc. (ABL) shares have increased by 3.7% over the past four weeks, closing at $10.30, with a mean price target of $13.67 indicating a potential upside of 32.7% [1] - The average price target consists of three estimates ranging from $12 to $15, with a standard deviation of $1.53, suggesting a relatively high agreement among analysts [1][4] - The lowest estimate suggests a 16.5% increase, while the highest points to a 45.6% upside [1] Group 2: Analyst Sentiment and Earnings Estimates - Analysts show strong agreement regarding ABL's ability to report better earnings than previously predicted, which supports the potential for stock upside [2][5] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 7.6%, with no negative revisions, indicating positive sentiment [5] - ABL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [5] Group 3: Price Target Limitations - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' ability to set accurate targets has been questioned [2][3] - Empirical research indicates that price targets often mislead investors rather than guide them, with analysts sometimes setting overly optimistic targets due to business incentives [3] - A low standard deviation in price targets indicates a high degree of agreement among analysts, which can be a starting point for further research [4]

New partnership leverages PREADISAN™, the cutting-edge health prediction platform using machine learning and modern proteomicsApplies novel big data analytics tools to the Abacus portfolio of servicesLorisco's risk scores will enable a more personalized approach to longevity and actuarial technology to maximize value for Abacus’ clients ORLANDO, Fla and NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity an ...

Abacus Life, Inc. (NASDAQ:ABL) Q2 2024 Earnings Conference Call August 12, 2024 9:00 AM ET Company Participants Garrett Edson - Managing Director ICR Jay Jackson - Chief Executive Officer Bill McCauley - Chief Financial Officer Conference Call Participants Crispin Love - Piper Sandler Andrew Kligerman - TD Securities Matthew Howlett - B. Riley Securities Operator Greetings and welcome to Abacus Life Second Quarter '24 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-an ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 85-1210472 ...